SCHEMBL5738360

SCHEMBL5738360

NCc1nc2c(Cl)c(Cl)ccc2[nH]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.37
GAA P10253 4/20 0.37
RAB9A P51151 4/20 0.37
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
TP53 P04637 1/20 0.37
CYP1A2 P05177 1/20 0.37
GLA P06280 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
CACNA1B Q00975 1/20 0.37
APBA1 Q02410 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23497511 0.81 CACNA1H (0.36) NPC1GAARAB9AALDH1A1CACNA1H
SCHEMBL5738314 0.79 PSMB8 (0.51) NPC1GAARAB9ASMN1; SMN2CYP1A2
SCHEMBL7045259 0.76 NUDT1 (0.60) NPC1GAARAB9AALDH1A1MEN1
SCHEMBL1625967 0.75 NPC1 (0.53) NPC1GAARAB9AALDH1A1MEN1
SCHEMBL7608556 0.74 GPR84 (0.41) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL3421747 0.72 HTT (0.52) NPC1GAARAB9AALDH1A1MEN1
SCHEMBL12309204 0.71 EGLN1 (0.42) CACNA1H
SCHEMBL5738714 0.71 CBFB (0.45) NPC1GAARAB9AALDH1A1SMN1; SMN2
SCHEMBL7231111 0.71 NPC1 (0.43) NPC1GAARAB9AALDH1A1MEN1
SCHEMBL5738369 0.71 CACNA1H (0.36) GAACACNA1HPNMTTDP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1176959-B1 NOVEL PROLINES AS ANTIMICROBIAL AGENTS MERCK & CO INC (US) 2006-03-08 EP disclosed
US-6579894-B2 Bactericides, fungicides MERCK & CO., INC. 2003-06-17 US disclosed
US-20030013724-A1 Novel prolines as antimicrobial agents HAMMOND MILTON L (US) 2003-01-16 US disclosed
EP-1176959-A4 NOVEL PROLINES AS ANTIMICROBIAL AGENTS MERCK & CO INC (US) 2002-10-09 EP disclosed
US-6417217-B1 TREATING INFECTIONS WITH HETEROCYCLIC MICROBIOCIDES THIS INVENTION RELATES TO THE FIELD OF TRANSFER RIBONUCLEIC ACID (TRNA) SYNTHETASE INHIBITORS, THEIR PREPARATION AND THEIR USE AS ANTIMICROBIAL ADMINISTERING TO THE SUBJECT A MERCK & CO., INC. 2002-07-09 US disclosed
EP-1176959-A1 NOVEL PROLINES AS ANTIMICROBIAL AGENTS Merck & Co., Inc. (US) 2002-02-06 EP disclosed
US-6333344-B1 ENZYME INHIBITORS AND BACTERICIDES MERCK & CO. 2001-12-25 US disclosed
WO-2000066119-A1 NOVEL PROLINES AS ANTIMICROBIAL AGENTS MERCK & CO., INC. (US) 2000-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013724-A1 Novel prolines as antimicrobial agents AARS1, EPRS1, TRMT1 NPC1 1838/4885GAA 1631/4885RAB9A 2175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.